Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bacteria infections
Biotech
Phage-focused BiomX reset may include defense sector pivot
Phage-focused BiomX is undergoing a “strategic and financial reset” in efforts to improve the biotech’s financial position.
Gabrielle Masson
Mar 19, 2026 11:00am
Experiments reveal targets for new tuberculosis vaccines
Nov 7, 2025 5:15am
GSK unveils pivotal data on oral antibiotic ahead of FDA filing
Oct 21, 2025 10:55am
Vaccine-probiotic combo clears gut infections in mice
Apr 9, 2025 5:25am
BiomX's bacteria-killing virus reduces bone ulcers in phase 2
Mar 31, 2025 9:05am
Harmless skin bacteria engineered to be living topical vaccine
Dec 11, 2024 11:00am